662 results on '"Gahete, Manuel D."'
Search Results
2. Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target
3. SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
4. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
5. Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity
6. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
7. Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response
8. Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1
9. Physiology of the Pituitary Hormone Secretion
10. Questions and Answers
11. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
12. PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
13. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
14. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes
15. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors
16. The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer.
17. Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
18. FRI-462-YI Aminoacyl-tRNA synthetases characterization and clinical potential in aggressive hepatocellular carcinoma
19. Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets
20. Characterization and targeting of serpins alteration in chronic liver disease and hepatocellular carcinoma
21. Dysregulation of RNA-Exosome machinery in MASLD-HCC progression
22. aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
23. Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers
24. Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma
25. Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?
26. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer
27. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
28. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer
29. Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types
30. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in Pancreatic Ductal Adenocarcinoma
31. LRP10, PGK1 and RPLP0: Best Reference Genes in Periprostatic Adipose Tissue under Obesity and Prostate Cancer Conditions
32. Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatment
33. THU550 The Splicing Factor SRSF6 Regulates Androgen Receptor Activity And Represents A Potential Therapeutic Target In Prostate Cancer
34. THU080 Splicing Machinery Dysregulation As A Source Of Novel Diagnostic, Prognostic And Therapeutic Targets In Craniopharyngiomas
35. The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features
36. Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors
37. The splicing factor SRSF6 regulates AR activity and represents a potential therapeutic target in prostate cancer
38. Strategic Designs to identify the best housekeeping genes for the characterization of biomarkers in adipose tissue of patients with obesity and cancer
39. Metformin Ameliorates Fatty Liver Disease in A High-Fat Diet-Induced Obese FVB/N Mouse Model
40. Therapeutic potential of the splicing factor SRSF6 as a novel regulator of the Androgen Receptor in prostate cancer
41. MiR-191-5p represents a potential personalized diagnostic and therapeutic tool for PCa patients, especially in obesity conditions
42. Characterization of telomerase/shelterin system in endocrine intracranial tumors at clinical, transcriptomic, and functional levels
43. Molecular and clinical relevance of the somatostatin system in brain tumors
44. Neuronostatin receptor GPR107 as a potential biomarker and therapeutic target in chronic liver disease
45. Pathophysiological role of splicing machinery in craniopharyngiomas: Novel source of diagnostic, prognostic and therapeutic biomarkers
46. Role of the Kiss1/Kiss1r system in the regulation of pituitary cell function
47. Models of GH deficiency in animal studies
48. Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker
49. Fasting modulates GH/IGF-I axis and its regulatory systems in the mammary gland of female mice: Influence of endogenous cortistatin
50. Aminoacyl-tRNA synthetases as diagnostic, prognostic, and therapeutic tools in MAFLD-derived hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.